Fund Holdings — BIOS Capital Management, LP

Total Portfolio Value
$52.87M
Total Bought
$615.8K
Total Sold
$2.22M
Net Transaction
-$1.60M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
OPUS GENETICS INC(IRD)3,683,4293,683,42907,40416,76031.70%+9,356
REIN THERAPEUTICS INC(RNTX)1,690,7511,982,375+291,6241,9612,5774.87%+616
IN8BIO INC253,417167,805-85,6125932480.47%-345
LANTERN PHARMA INC(LTRN)1,009,507864,435-145,0723,0591,1842.24%-1,875
COGNITION THERAPEUTICS INC(CGTX)6,000,0006,000,00008,1004,5608.63%-3,540
ACTUATE THERAPEUTICS INC10,049,99610,049,996061,50627,53752.09%-33,969
Page 1 of 1
BIOS Capital Management, LP — 13F Holdings — Q1 2026 | TickerTrail